Investors
Investment Opportunities are Available
Imagenetix is an innovator of scientifically tested, natural-based, proprietary bioceutical products developed to enhance human health on a global basis. Imagenetix develops, formulates and markets its own line of branded products in the mass market, as well as sells on a private-label basis propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. Additionally, the company develops pharmaceutical compounds designed to treat inflammatory related diseases.
Imagenetix is currently traded on NASDAQ:
- Symbol: IAGX
- Shares Outstanding: 11,010,788
- Warrants and Options Outstanding: 6,367,957
- Fully Diluted: 17,378,745
Safe Harbor StatementThis document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company’s products and services. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the company has filed and will periodically file with the Securities Exchange Commission.